Institutional private equity firms are sitting on historic levels of dry powder in 2026. For middle-market business owners, unlocking this liquidity requires navigating sophisticated quality of earnings (QofE) audits, structured rollover equity, and aggressive leveraged buyout financial models.

Not sure which funding path fits your healthcare business? Here's every real option — from angel investment to SAFE notes to non-dilutive grants — compared side by side.

A start-to-finish roadmap for medical startups and healthcare startup companies raising capital in 2026 — from pre-seed to Series A, covering SAFE notes, capital raises, and where healthcare founders actually find investors.

In an era of strict equity underwriting and valuation compression, high-growth startups are turning to non-dilutive liquidity instruments. Discover how venture cash advances and merchant cash advances for startup business models allow founders to secure immediate non-dilutive growth capital without surrendering equity to institutional venture capital.

Finding capital shouldn't feel like cold-calling in the dark. Discover the top platforms and strategies to connect with investors looking for active companies in 2026.